Drug Profile
Lamivudine/zidovudine - Aspen Pharmacare
Alternative Names: Aspen Lamzid; Zidovudine/lamivudine - Aspen PharmacareLatest Information Update: 08 Oct 2021
Price :
$50
*
At a glance
- Originator Aspen Pharmacare
- Class Antiretrovirals; Azides; Dideoxynucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed HIV-1 infections
Most Recent Events
- 08 Oct 2021 Lamivudine/zidovudine is not yet available for HIV-1 infection in USA